Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma
- 1 January 1976
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 6 (3) , 376-388
- https://doi.org/10.1016/0090-1229(76)90091-x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Antileukotactic properties of tumor cells.Journal of Clinical Investigation, 1975
- LASMA AND CELL‐DERIVED INHIBITORS OF HUMAN NEUTROPHIL CHEMOTAXISAnnals of the New York Academy of Sciences, 1975
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974
- Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation of BCG: Correlation with cell-mediated immunityInternational Journal of Cancer, 1974
- A NEUTROPHIL-IMMOBILIZING FACTOR DERIVED FROM HUMAN LEUKOCYTESThe Journal of Experimental Medicine, 1972
- Immunity to Neuroblastomas and MelanomasAnnual Review of Medicine, 1972
- IMMUNE PHAGOCYTOSIS IN VIVO OF HUMAN MALIGNANT MELANOMA CELLSActa Medica Scandinavica, 1972
- A Method for Assessing thein vitroChemotactic Response of Neutrophils Utilizing51FR-Labeled Hliman LeukocytesImmunological Communications, 1972
- The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factorCellular Immunology, 1970
- CUTANEOUS HYPERSENSITIVITY REACTIONS TO AUTOLOGOUS EXTRACTS OF MALIGNANT MELANOMA CELLSThe Lancet, 1970